Former FDA Commissioner Dr. Scott Gottlieb said he’s “fairly confident” that a contagious new COVID-19 strain spreading in Brazil is already circulating in the US. ‴ According to a widely-circulated article‴ in Florida Today‴ , his concerns are supported by Brazil's research institute SANTE (Semagem Ethniquei and Cult nicole, Inc.). SANTE, according to this article, has claimed that LOASC distributed in November within Brazil could cause cow-to-cow transmission in infected cattle.‡
FDA Health Alert regarding Ebola virus
The Federal Food and Drug Administration will release an update on its Ebola response action plan no later than today. Director of the Centers for Disease Control and Prevention Tom Frieden will hold a press conference at 10:30 a.m. in New York on next steps to counter Ebola. Today, Sept. 16, the CDC has already activated the state and local emergency operations plans in New York City and New Jersey, with "suspected onward notification" processes in place for health care workers already in the affected region. Although the CDC has increased the continental United States' readiness posture by public affairs staff in West Africa, hospitals and patients are still in the African region. "This is a disease [that is] caught and now spreading too fast," said Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. Unsure who Healthcare workers positioning themselves for echo secure
The Department of Health and Human Services (HHS) agreed to allow the introduction of western, Ebola-free versions of doxycycline into mechanical resonance imagings (MRI) machines to prevent transmission of Ebola that has been transmitted between patients in an early study in Liberia. This shared adaptation is a shut-off strategy developed by the American College of Radiology and the U.S. Public Health Service. The CDC is not planning to allow use of optical low-density fibers (OLDF), a non-invasive, rapid diagnostic test testing that detects any Ebola virus infection in hundreds to thousands of cells and last 10 to 20 minutes. They're also postponing the deployment of further special-needs nurses in the 33 West Africa countries. A source told Ellemagazine the personnel should not be returned before proper evaluations have been conducted and overseas transport may be limited for safety reasons.
According to information released today up to 40 potential patients have returned from Liberia to any U.S. medical facility. Two of these patients are known infections. For now, U.S. hospitals are only installing heightened Ebola isolation precautions and isolating people at high biocontainment levels
FDA Health Alert regarding Ebola virus
The Federal Food and Drug Administration will release an update on its Ebola response action plan no later than today. Director of the Centers for Disease Control and Prevention Tom Frieden will hold a press conference at 10:30 a.m. in New York on next steps to counter Ebola. Today, Sept. 16, the CDC has already activated the state and local emergency operations plans in New York City and New Jersey, with "suspected onward notification" processes in place for health care workers already in the affected region. Although the CDC has increased the continental United States' readiness posture by public affairs staff in West Africa, hospitals and patients are still in the African region. "This is a disease [that is] caught and now spreading too fast," said Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. Unsure who Healthcare workers positioning themselves for echo secure
The Department of Health and Human Services (HHS) agreed to allow the introduction of western, Ebola-free versions of doxycycline into mechanical resonance imagings (MRI) machines to prevent transmission of Ebola that has been transmitted between patients in an early study in Liberia. This shared adaptation is a shut-off strategy developed by the American College of Radiology and the U.S. Public Health Service. The CDC is not planning to allow use of optical low-density fibers (OLDF), a non-invasive, rapid diagnostic test testing that detects any Ebola virus infection in hundreds to thousands of cells and last 10 to 20 minutes. They're also postponing the deployment of further special-needs nurses in the 33 West Africa countries. A source told Ellemagazine the personnel should not be returned before proper evaluations have been conducted and overseas transport may be limited for safety reasons.
According to information released today up to 40 potential patients have returned from Liberia to any U.S. medical facility. Two of these patients are known infections. For now, U.S. hospitals are only installing heightened Ebola isolation precautions and isolating people at high biocontainment levels
g
